Off-label information
Executive Summary
Meeting on FDA proposed rule for dissemination of journal reprints relating to unapproved new uses for marketed drugs, biologics and devices will be held July 8. Sponsored by FDA's Office of Consumer Affairs, the meeting will be held at the HHS Wilbur J. Cohen Building in Washington, D.C. at 1:30 p.m